Medicare Enrolled
Dr. Gwyn Londeree, M.D.
Optician · Columbus, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Londeree from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Londeree?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Londeree
Dr. Gwyn Londeree is an optician specialist in Columbus, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Londeree performed 4,764 Medicare services across 3,190 unique beneficiaries.
Between the years covered by Open Payments, Dr. Londeree received a total of $19,402 from 50 pharmaceutical and/or device companies across 1212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Londeree is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in OH
$19,402 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,764
Medicare services
Top 7% in OH for optician
3,190
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~238 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,386 | $55 | $129 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,097 | $5 | $25 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
490 | $39 | $90 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
340 | $33 | $89 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
317 | $64 | $131 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
251 | $65 | $186 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
128 | $1 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
76 | $92 | $145 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
71 | $37 | $80 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
71 | $197 | $400 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
59 | $70 | $146 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
56 | $29 | $75 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
50 | $10 | $35 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
44 | $90 | $165 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 36 | $236 | $405 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
34 | $115 | $301 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
32 | $100 | $675 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
31 | $31 | $143 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
26 | $90 | $328 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
23 | $65 | $272 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $83 | $220 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
18 | $218 | $399 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
17 | $199 | $346 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
16 | $89 | $161 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
14 | $98 | $418 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
13 | $152 | $333 |
| Removal of noncancer skin growth, 2.1-3.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The excised tissue measures between 2.1 and 3.0 centimeters in diameter. |
12 | $75 | $295 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
12 | $92 | $486 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | 11 | $275 | $474 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 11 | $124 | $338 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$19,402
Total received (2018-2024)
Avg $2,772/year across 7 years
Top 10% in OH for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
1,212
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,154 (93.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,247 (6.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,404
2023
$2,994
2022
$2,461
2021
$1,994
2020
$1,698
2019
$2,765
2018
$3,086
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$751
Janssen Biotech, Inc.
$628
Dermavant Sciences, Inc.
$288
SUN PHARMACEUTICAL INDUSTRIES INC.
$257
E.R. Squibb & Sons, L.L.C.
$224
Arcutis Biotherapeutics, Inc.
$223
PFIZER INC.
$221
Galderma Laboratories, L.P.
$218
LEO Pharma Inc.
$192
GENZYME CORPORATION
$176
REVANCE THERAPEUTICS, INC.
$165
UCB, Inc.
$159
Lilly USA, LLC
$143
Krystal Biotech Inc
$130
Amgen Inc.
$114
Novartis Pharmaceuticals Corporation
$104
MAYNE PHARMA COMMERCIAL LLC
$97
Regeneron Healthcare Solutions, Inc.
$87
Verrica Pharmaceuticals Inc.
$67
Incyte Corporation
$58
Organogenesis Inc.
$39
Kyowa Kirin, Inc.
$35
Almirall LLC
$14
STRATA Skin Sciences, Inc.
$14
Top 3 companies account for 37.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$2,204
ABBVIE INC.
$2,041
Galderma Laboratories, L.P.
$1,586
Sun Pharmaceutical Industries Inc.
$1,087
Novartis Pharmaceuticals Corporation
$835
AbbVie, Inc.
$812
Amgen Inc.
$794
UCB, Inc.
$744
GENZYME CORPORATION
$661
Lilly USA, LLC
$628
PFIZER INC.
$622
LEO Pharma Inc.
$573
Biofrontera Inc.
$536
Arcutis Biotherapeutics, Inc.
$509
Celgene Corporation
$493
Dermavant Sciences, Inc.
$482
SUN PHARMACEUTICAL INDUSTRIES INC.
$452
AbbVie Inc.
$432
Regeneron Healthcare Solutions, Inc.
$408
E.R. Squibb & Sons, L.L.C.
$378
Allergan Inc.
$265
NOVARTIS PHARMACEUTICALS CORPORATION
$228
Almirall LLC
$222
Ortho Dermatologics, a division of Bausch Health US, LLC
$210
Merz North America, Inc.
$189
Journey Medical Corporation
$182
Incyte Corporation
$181
MAYNE PHARMA COMMERCIAL LLC
$176
REVANCE THERAPEUTICS, INC.
$165
EPI Health, LLC
$145
Medimetriks Pharmaceuticals, Inc.
$139
Krystal Biotech Inc
$130
Taro Pharmaceuticals USA, Inc.
$129
STRATA Skin Sciences, Inc.
$99
DERMIRA, INC.
$92
PruGen, Inc. Pharmaceuticals
$80
Verrica Pharmaceuticals Inc.
$67
Mayne Pharma Inc.
$57
Sandoz Inc.
$41
Bayer HealthCare Pharmaceuticals Inc.
$41
Allergan, Inc.
$41
Organogenesis Inc.
$39
Genentech USA, Inc.
$39
Aclaris Therapeutics, Inc.
$38
Kyowa Kirin, Inc.
$35
Helsinn Therapeutics (U.S.), Inc.
$24
MAYNE PHARMA INC.
$22
ARBOR PHARMACEUTICALS, INC.
$17
Exeltis, USA Inc.
$15
Mylan Pharmaceuticals Inc.
$15
Top 3 companies account for 30.1% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · APEXICON E · ARAZLO · Absorica LD · Ameluz · BLU-U · BOTOX · BOTOX COSMETIC · BRYHALI · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DAXXIFY · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · EFUDEX · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · FINACEA · Finacea · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Horizant · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · KERYDIN · Klisyri · LITFULO · Neo-Synalar · Neo-Synalar Cream · Neocera · OLUMIANT · OPZELURA · ORACEA · Otezla · PICATO · Poteligeo · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · STELARA · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · Tremfya · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VALCHLOR · VTAMA · VYJUVEK · Veltin · WYNZORA · Winlevi · XEOMIN · XTRAC · Xeomin · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for optician in OH.
Geographic Context
Opticians within 10 mi
256
Per 100K population
19.4
County median income
$73,795
Nearest hospital
RIVERSIDE METHODIST HOSPITAL
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Londeree is a clinical cardiology specialist, with above-average Medicare volume (top 7% in OH), with low-engagement industry engagement in the top 10% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Londeree experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Londeree performed 1,386 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Londeree receive payments from pharmaceutical companies?
Yes. Dr. Londeree received a total of $19,402 from 50 companies across 1,212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Londeree's costs compare to other opticians in Columbus?
Dr. Londeree's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Londeree) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Columbus
Browse opticians in Columbus ranked by procedure volume and transparency data.
Highest volume
Top Opticians in OH
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in OH
Which OH opticians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology